Key result
Despite worse baseline characteristics, women undergoing PCI with paclitaxel-eluting stents had similar 12-month rates of cardiac death (2.0% vs 2.1%, p=NS) compared to men.
Why the study?
Does gender affect outcomes after percutaneous coronary intervention with paclitaxel-eluting stents?
Cohort (n=4,325)
Does gender affect outcomes after percutaneous coronary intervention with paclitaxel-eluting stents?
Absolute Event Rate: 2% vs 2.1%
p-value: p=NS
Despite worse baseline clinical and angiographic characteristics in women, outcomes after PCI with paclitaxel-eluting stents are similar between sexes at 12 months.
No takes yet. Share an insight, caveat, or question.
Similar short-term cardiac mortality despite higher-risk features in women supports equitable stent selection; leaves open need for randomized long-term confirmation.
Presbitero et al. (2008) conducted a cohort in Percutaneous coronary intervention (n=4,325). Female sex vs. Male sex was evaluated on Cardiac death at 12 months (p=NS). Despite worse baseline characteristics, women undergoing PCI with paclitaxel-eluting stents had similar 12-month rates of cardiac death (2.0% vs 2.1%, p=NS) compared to men.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: